GlassScriptPhysician profile
Julio Ugarte
NPI 1942246889
$12,497.71
in general payments reported to CMS, 2019-2025
55 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,673 · 2020: $1,973 · 2021: $1,959 · 2022: $2,389 · 2023: $1,409 · 2024: $1,533 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,503.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,377.17 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $893.24 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $858.35 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $735.83 | 2019-2023 | |
| Biotronik INC. | $726.37 | 2022 | |
| Amgen INC. | $555.12 | 2019-2025 | Evenity, Prolia, Krystexxa |
| Merck Sharp & Dohme LLC | $548.46 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Abbvie INC. | $525.83 | 2019-2025 | Ubrelvy, Linzess, Viberzi |
| Mylan Specialty L.P. | $485.57 | 2019-2024 | Yupelri |
| Sumitomo Pharma America, INC. | $444.63 | 2023-2025 | Gemtesa |
| Lilly USA, LLC | $404.26 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Pfizer INC. | $357.13 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $350.35 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $335.93 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $280.88 | 2019-2022 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $259.27 | 2019-2023 | Seglentis, Livalo |
| Allergan, INC. | $228.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.68 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $173.76 | 2022-2024 | |
| Renalytix Ai, INC. | $170.01 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.01 | 2019-2025 | Xifaxan, Trulance |
| Viatris Specialty LLC | $145.06 | 2025 | Yupelri |
| Stryker Corporation | $143.00 | 2021 | |
| Exact Sciences Corporation | $133.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $131.88 | 2024-2025 | Rexulti |
| Boston Scientific Corporation | $123.66 | 2024-2025 | Watchman Flx, General - Pain Management |
| Astellas Pharma US INC | $121.99 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $120.17 | 2021-2023 | |
| Smith+Nephew, INC. | $116.67 | 2022 | |
| Idorsia Pharmaceuticals US INC | $110.57 | 2022-2023 | Quviviq |
| Tosoh Bioscience, INC. | $110.00 | 2019 | |
| Antares Pharma, INC. | $101.89 | 2019-2022 | |
| Daiichi Sankyo INC. | $99.90 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $92.45 | 2022-2023 | Ajovy, Austedo |
| Philips North America LLC | $91.60 | 2020-2025 | Ecc Solutions, (Ck4) Mcot, Extended Holter |
| Esperion Therapeutics, INC. | $79.63 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $76.95 | 2019-2023 | Eliquis |
| Arbor Pharmaceuticals, INC. | $62.51 | 2019-2021 | |
| Ibsa Pharma INC. | $62.34 | 2020-2021 | |
| Abbott Laboratories | $58.74 | 2021-2023 | Freestyle Libre 2 |
| Eisai INC. | $54.65 | 2021-2022 | |
| Sanofi Pasteur INC. | $54.53 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $52.09 | 2022 | |
| Radius Health, INC. | $49.46 | 2020 | |
| Azurity Pharmaceuticals, INC. | $38.72 | 2025 | Horizant, Alvesco |
| Dexcom, INC. | $29.35 | 2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $29.17 | 2021 | |
| Phathom Pharmaceuticals, INC. | $24.83 | 2025 | Voquezna |
| Lifescan, INC. | $21.34 | 2023 | |
| Bioventus LLC | $20.41 | 2022 | |
| Aimmune Therapeutics, INC. | $19.77 | 2024 | |
| Axsome Therapeutics, INC. | $18.56 | 2025 | Auvelity |
| Shire North American Group INC | $18.27 | 2019 | |
| Medtronic Vascular, INC. | $15.75 | 2019 | |
| Biosense Webster, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Ugarte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.